XML 32 R17.htm IDEA: XBRL DOCUMENT v3.24.2
Accounts Receivable
 6 Months Ended
Jun. 30, 2024
Trade and other receivables [abstract]  
Accounts Receivable
B.7. ACCOUNTS RECEIVABLE
Accounts receivable break down as follows:
(€ million)June 30, 2024December 31, 2023
Gross value8,602 8,528 
Allowances(92)(95)
Carrying amount8,510 8,433 
The impact of allowances against accounts receivable in the first half of 2024 was a net expense of €3 million (versus a net expense of €2 million for the first half of 2023).
The table below shows the ageing profile of overdue accounts receivable, based on gross value:
(€ million)Overdue accounts gross valueOverdue by <1 monthOverdue by 1-3 monthsOverdue by 3-6 monthsOverdue by 6-12 monthsOverdue by > 12 months
June 30, 2024646 264 105 137 69 71 
December 31, 2023689 269 154 123 62 81 
Some Sanofi subsidiaries have assigned receivables to factoring companies or banks without recourse. The amount of receivables that met the conditions described in Note B.8.6. to the consolidated financial statements for the year ended December 31, 2023 and hence were derecognized was €503 million as of June 30, 2024 (versus €761 million as of December 31, 2023). The residual guarantees relating to those transfers were immaterial as of June 30, 2024.